The ERDERA partnership was launched in September 2024, with a budget of 380 million euros & uniting over 170 organisations. It will coordinate national, local and European research and innovation programmes, combining research funding and implementation of research supportive activities such as training, data access infrastructures, data standards etc.

The main goal is to improve the life of patients with rare diseases by developing diagnostics and treatments for rare diseases through multidisciplinary research and innovation programmes with all relevant stakeholders. This will increase impact and uptake of research results as well as increase the visibility of EU leadership in rare diseases research.

Past & current calls for proposals

Since it took off in 2024, ERDERA has launched 1 joint transnational call. ERDERA has announched it will soon launch it's first Clinical Trials call. Find out more on the funding page on the ERDERA website. 

Timeline & key documents

• More information on the partnership can be found in the draft outline of partnership proposal (February 2022).
• A first version of the Strategic Research & Innovation Agenda that will underpin the Partnership was published in Spring 2023 in the context of a public consultation. The SRIA is yet to be finalised.
• The partners involved in the European Joint Programme on Rare Diseases (EJP RD) have played an important role in the preparation of the SRIA. 
• The partnership proposal was submitted on 19 September 2023 for funding under Horizon Europe as a co-funded partnership between the European Commission, European Member States, and beyond.
• The Partnership was launched in September 2024. Read all about it here. 

Contact

Subscribe to the ERDERA newsletter here.

Contact ERDERA via the contact form on the ERDERA website: ERDERA - European Rare Diseases Research Alliance

Commission services: RTD-RD-PARTNERSHIP@ec.europa.eu